These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 15151905
1. Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow. Ni CW, Hsieh HJ, Chao YJ, Wang DL. Am J Physiol Cell Physiol; 2004 Sep; 287(3):C771-80. PubMed ID: 15151905 [Abstract] [Full Text] [Related]
2. Shear flow attenuates serum-induced STAT3 activation in endothelial cells. Ni CW, Hsieh HJ, Chao YJ, Wang DL. J Biol Chem; 2003 May 30; 278(22):19702-8. PubMed ID: 12637510 [Abstract] [Full Text] [Related]
3. JAK2/STAT3, not ERK1/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes. Yu X, Kennedy RH, Liu SJ. J Biol Chem; 2003 May 02; 278(18):16304-9. PubMed ID: 12595539 [Abstract] [Full Text] [Related]
4. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3. Huang A, Zhang YY, Chen K, Hatakeyama K, Keaney JF. Circ Res; 2005 Feb 04; 96(2):164-71. PubMed ID: 15604419 [Abstract] [Full Text] [Related]
8. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. Li WQ, Dehnade F, Zafarullah M. J Immunol; 2001 Mar 01; 166(5):3491-8. PubMed ID: 11207308 [Abstract] [Full Text] [Related]
9. Structure and function of a new STAT-induced STAT inhibitor. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. Nature; 1997 Jun 26; 387(6636):924-9. PubMed ID: 9202127 [Abstract] [Full Text] [Related]
10. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation. Iwamoto T, Senga T, Naito Y, Matsuda S, Miyake Y, Yoshimura A, Hamaguchi M. Oncogene; 2000 Sep 28; 19(41):4795-801. PubMed ID: 11032030 [Abstract] [Full Text] [Related]
13. The Jak-STAT pathway stimulated by interleukin 6. Horvath CM. Sci STKE; 2004 Nov 23; 2004(260):tr9. PubMed ID: 15561981 [Abstract] [Full Text] [Related]
14. ICAM-1 induction by TNFalpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells. Wung BS, Ni CW, Wang DL. J Biomed Sci; 2005 Nov 23; 12(1):91-101. PubMed ID: 15864742 [Abstract] [Full Text] [Related]
15. Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Chatterjee PK, Al-Abed Y, Sherry B, Metz CN. Am J Physiol Cell Physiol; 2009 Nov 23; 297(5):C1294-306. PubMed ID: 19741199 [Abstract] [Full Text] [Related]
16. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism. Shen X, Tian Z, Holtzman MJ, Gao B. Biochem J; 2000 Dec 15; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703 [Abstract] [Full Text] [Related]
20. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Badache A, Hynes NE. Cancer Res; 2001 Jan 01; 61(1):383-91. PubMed ID: 11196191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]